VEGFB and endometrial cancer: The overwhelming majority of CNAs were amplification of genes, and the amplification of VEGFB gene was the most frequent CNA which was presented in 20/115 samples of which 19/20 were endometrial cancer (95%) and 1/20 were EIN (5%).